Contrast-enhanced ocular imaging

• US 20060032507A1
• Filed: 08/11/2004
• Published: 02/16/2006
• Est. Priority Date: 08/11/2004
• Status: Abandoned Application

• Current Assignee: Glaukos Corporation
• Original Assignee: Glaukos Corporation
• Inventors: Tu, Hosheng
• Application Number:
  US10/915,831
• Publication Number:
  US 20060032507A1
• Time in Patent Office: Days
• US Class Current: 128/898
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

The invention relates generally to medical devices and methods for ocular imaging and, more particularly, to devices and methods for increasing contrast in an eye in which an imaging contrast agent is introduced into an aqueous humor outflow channel. For example, in one embodiment, the outflow channel may be Schlemm'"'"'s Canal, or in another embodiment, the outflow channel may be an episcleral vein. Also disclosed are methods for implanting a trabecular stent via an ab extemo procedure with assistance of enhanced magnetic resonance imaging to restore a part or all of the normal physiological function of directing aqueous outflow for maintaining a normal intraocular pressure in an eye.

Claims

1. A method of increasing contrast in an eye, the method comprising:

introducing an imaging contrast agent into an aqueous humor outflow channel of the eye.

2. The method of claim 1, wherein the outflow channel is Schlemm'"'"'s Canal.

3. The method of claim 1, wherein the outflow channel is an aqueous collector channel.

4. The method of claim 1, wherein the outflow channel is an episcleral vein.

5. The method of claim 1, wherein the contrast agent is an iodinated contrast agent.

6. The method of claim 1, wherein the contrast agent is a ferromagnetic contrast agent.

7. The method of claim 1, wherein the contrast agent is an echogenic contrast agent.

8. The method of claim 7, wherein the echogenic contrast agent comprises microbubbles.

9. The method of claim 1, wherein said introducing comprises injecting.

10. The method of claim 5, further comprising imaging said eye with Computed X-ray Tomography.

11. The method of claim 6, further comprising imaging said eye with magnetic resonance.

12. The method of claim 7, further comprising imaging said eye with ultrasound.

13. The method of claim 1, further comprising inserting an implant in the eye such that an inlet portion of the implant conducts fluid from the anterior chamber to an outlet portion of the implant residing outside the anterior chamber.